Validation of the 3D Skin Comet assay using full thickness skin models: transferability and reproducibility
-
1
Henkel AG & Co KGaA, Germany
The 3D Skin Comet assay was developed to improve the in vitro prediction of the genotoxic potential of dermally applied chemicals. For this purpose, a classical read-out for genotoxicity (i.e. comet formation) was combined with reconstructed 3D skin models as well-established test systems. Five laboratories (BASF, BfR (Federal Institute for Risk Assessment), Henkel, Procter & Gamble and TNO Triskilion) started to validate this assay using the Phenion® Full- Thickness (FT) Skin Model and 8 coded chemicals with financial support by Cosmetics Europe and the German Ministry of Education & Research.
There was an excellent overall predictivity of the expected genotoxicity (>90%). Four labs correctly identified all chemicals and the fifth correctly identified 80% of the chemicals. Background DNA damage was low and values for solvent (acetone) and positive (methyl methanesulfonate (MMS)) controls were comparable among labs. Inclusion of the DNA-polymerase inhibitor, aphidicolin (APC), in the protocol improved the predictivity of the assay since it enabled robust detection of pro-mutagens e.g., 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene. Therefore, all negative findings are now confirmed by additional APC experiments to come to a final conclusion. Furthermore, MMC, which intercalates between DNA strands causing covalent binding, was detected with the standard protocol, in which it gave weak but statistically significant responses. Stronger responses, however, were obtained using a cross-linker specific protocol in which MMC reduced the migration of MMS-induced DNA damage. These data support the use of the Phenion® FT in the Comet assay: no false-positives and only one false-negative finding in a single lab. Testing will continue to obtain data for 30 chemicals. Once validated, the 3D Skin Comet assay is foreseen to be used as a follow-up test for positive results from the current in vitro genotoxicity test battery.
Acknowledgements
3D Skin Comet assay team
Pfuhler S, Bartel M, Blatz V, Brinkmann J, R., Engels U, Fischer A, Henkler F, Hoffmann S, Jeschke S, Krul C, Liebsch M, Luch A, Pirow R, Reus AA, Schulz M, Pfuhler S, Reisinger K
Cosmetics Europe
Pfuhler S, Fautz R, Klaric M, Hewitt N, Kenny J, Kühnl J, Fowler P, Ouédraogo G,
Keywords:
3D Skin Comet assay,
Full-Thickness Skin Models,
In vitro comet assay,
Validation study,
Regulatory acceptance
Conference:
ICAW 2015 - 11th International Comet Assay Workshop, Antwerpen, Belgium, 1 Sep - 4 Sep, 2015.
Presentation Type:
Oral Presentation
Topic:
The comet assay in Regulatory Toxicology
Citation:
Reisinger
K
(2015). Validation of the 3D Skin Comet assay using full thickness skin models: transferability and reproducibility.
Front. Genet.
Conference Abstract:
ICAW 2015 - 11th International Comet Assay Workshop.
doi: 10.3389/conf.fgene.2015.01.00001
Copyright:
The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers.
They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.
The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.
Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.
For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.
Received:
02 Jun 2015;
Published Online:
23 Jun 2015.
*
Correspondence:
Dr. Kerstin Reisinger, Henkel AG & Co KGaA, Dusseldorf, Germany, kerstin.reisinger@henkel.com